A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

February 29, 2008

Conditions
Advanced MalignanciesTumors
Interventions
DRUG

Patupilone/EPO906

Trial Locations (3)

78229

Institute for Drug Development Cancer Therapy & Research Center/The University of Texas Health Science Center, San Antonio

South Texas Accelerated Research Therapeutics, San Antonio

92093-0987

University of California San Diego/Moores Cancer Center, La Jolla

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY